Navigation Links
Lipitor Lawsuit Website Launched by Bernstein Liebhard LLP to Provide Information to the Public Regarding Lipitor Side Effects, Ongoing Litigation
Date:9/7/2013

New York, New York (PRWEB) September 07, 2013

A new Lipitor lawsuit (http://www.thelipitorlawsuit.com/) website has been launched by Bernstein Liebhard LLP to provide information to members of the public who may be concerned about possible Lipitor side effects, including:

  •     Type 2 Diabetes
  •     Skeletal Muscle Side Effects (myopathy and rhabdomyolysis)
  •     Kidney or Liver Damage

The Firm’s Lipitor lawsuit website will also be updated regularly to provide visitors with the most current information regarding the growing products liability litigation involving Lipitor and diabetes.

“We have received a number of inquiries from patients seeking information about Lipitor lawsuits, all of whom developed diabetes or some other side effect that could be tied to the use of this statin drug. This website will provide valuable information to worried patients and their families regarding the potential risks associated with Lipitor, as well as their options for legal recourse,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Lipitor lawsuit consultations to anyone who may have been harmed by this medication.

Lipitor Diabetes Lawsuits
Lipitor, which was brought to market in 1996, is a statin drug used to treat high cholesterol. In January 2012, a study published in JAMA: Internal Medicine reported that post-menopausal women who take Lipitor may be at an increased risk for developing diabetes.* The following month, the U.S. Food & Drug Administration (FDA) ordered the manufacturer of Lipitor to add new warnings to its label regarding this potential risk. Then in May 2013, another study published in the British Medical Journal reported that people taking Lipitor had a 22 percent higher risk of new-onset diabetes.**

In February 2011, the FDA warned of the potential for serious skeletal muscle side effects in patients taking Lipitor who were also being treated with protease inhibitors, a class of drugs used to treat HIV and hepatitis C.*** In March 2013, the British Medical Journal reported that patients treated with drugs like Lipitor faced a 30% increased risk of being hospitalized for acute kidney damage within four months of initiating Lipitor treatment****

Court documents indicate that a number of Lipitor lawsuits have been filed on behalf of patients who developed Type 2 diabetes, allegedly due to their use of the statin. In August, the U.S. Judicial Panel on Multidistrict Litigation rejected a request by plaintiffs to consolidate all Lipitor diabetes lawsuits in a single federal court for pretrial proceedings. However, individuals who believe they may have developed diabetes due to their use of Lipitor can still pursue product liability claims against the manufacturer of this drug. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2459 (JPML))

Individuals who took Lipitor and developed diabetes, skeletal muscle side effects, or kidney or liver damage, may be entitled to compensation for medical bills, lost wages, and pain and suffering. Learn More about filing a Lipitor lawsuit at Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 2012
**bmj.com/content/346/bmj.f2610, BMJ, May 2013
***fda.gov/Safety/MedWatch/SafetyInformation/Safety-RelatedDrugLabelingChanges/ucm133531.htm, FDA, February 2011
****bmj.com/content/346/bmj.f880, BMJ, March 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.thelipitorlawsuit.com/

Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb11099636.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. National Law Firm Baron and Budd Helping Women with Alleged Injuries from Lipitor Use Understand the Lipitor Lawsuit
2. National Law Firm Baron and Budd Responds to Disproportionate Harm Brought to Women Using Lipitor, According to Study
3. Lipitor News: Rottenstein Law Group LLP Comments on Boomers’ Favorite Drug
4. Lipitor Lawsuit News: Rottenstein Law Group LLP Responds to Reports of Lipitor Giveaway
5. Lipitor Lawsuit News: US Spending on Drugs Fell For First Time in 2012, Notes Rottenstein Law Group LLP
6. Lipitor Lawsuit News: Rottenstein Law Group Comments on FDA Approval of New Drug With Lipitor Compound
7. Lipitor Diabetes Lawsuit Filed by South Carolina Woman Who Developed Type 2 Diabetes Allegedly Due to Lipitor Use, Alonso Krangle Investigating
8. DrugRisk Update: Latest Court Order Moves Mirena Lawsuits Forward
9. DePuy Metal Hip Implant Lawsuits Help: Resource4thePeople Reports Billions in Settlements Considered as Key Trial Approaches
10. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conferences in State, Federal Stryker Hip Recall Litigations
11. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Looks Forward to Start of First Bellwether Trial in Federal DePuy ASR Recall Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... SANTA CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... government and financial organizations, today announced it has partnered with WALLIX to ... NIST Special Publication 800-171 . , There are a number of ways to address ...
(Date:7/24/2017)... ... July 24, 2017 , ... Anyone who uses scales know they ... would a pharmacist using that same scale to dispense medication. The first example is ... These illustrations show why it is important to have the right balance for the ...
(Date:7/24/2017)... ... 24, 2017 , ... A Southern California-based author has released a new book ... she has overcome them. “Forbidden Memories: A Memoir,” by author Michelle V. Madsen, highlights ... risen above. , In “Memories,” readers get a firsthand look at what Michelle has ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... how to change manufacturers future. , The agency is hammering out a game ... one of the farthest-ranging laws ever to affect FDA-regulated firms. The new law:, ...
(Date:7/24/2017)... ... 24, 2017 , ... “A Short Walk to the Mailbox”: a remarkable memoir ... of published author, Ed Clark. Ed Clark is a church music director and ... a minister of music and worship leader for over fifty years. He has ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... S.C. , July 10, 2017  BDI ... purchasing and patient support services organization serving specialty ... today the launch of four significant, value-added member ... market insights, better manage reimbursement and improve access ... and factor therapies. ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology: